The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,375.00
Bid: 11,200.00
Ask: 11,550.00
Change: -100.00 (-0.88%)
Spread: 350.00 (3.125%)
Open: 11,275.00
High: 11,200.00
Low: 11,200.00
Prev. Close: 11,300.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Dia-Stron Limited

1 Apr 2016 07:00

RNS Number : 8058T
Judges Scientific PLC
01 April 2016
 

Press Release

1 April 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Acquisition of Dia-Stron Limited

 

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces that it has today acquired 100% of the issued share capital of Dia-Stron Limited ("Dia-Stron"), an instrument maker based in Andover, Hampshire. Dia-Stron designs and manufactures systems to test the mechanical properties of fibres (the "Acquisition"). The Board expects the Acquisition to be immediately earnings enhancing.

 

The purchase price of Dia-Stron amounted to £2.75 million in cash. An additional payment will be made to reflect any excess working capital over and above the ongoing requirements of the business. The Board expects such payment to be covered by the cash inherited at the completion date.

 

Information on Dia-Stron

Dia-Stron specialises in the design and manufacture of systems to test the mechanical properties of fibres, primarily in relation to tensile strength. The company is a market leader in testing natural hair fibres and approximately 75 per cent of revenues are derived from the hair care industry, including large multi-national groups. The balance of sales is comprised of industrial fibres, skin-testing instruments and contract testing for third parties. The automation built into the company's systems provides significant efficiency savings for customers.

 

All of Dia-Stron's products are designed by the company, manufactured in Hampshire and sold worldwide to end users directly, through agents or through the company's US office ("Dia-Stron US"). The company's contract testing activities have, historically, been conducted in the US by Mar-Tech Contract Services Inc., a related company ("Mar-Tech); these activities, along with certain assets of Dia-Stron US, were transferred to Dia-Stron in the UK prior to completion of the Acquisition.

 

Dia-Stron was established in 1987 by Dr Nigel Winsey (Managing Director), Mrs Lynn Winsey (Finance Director and Company Secretary), Dr Steve Bucknell (Technical Director) and Mrs Tessa Bucknell (shareholder). Dr Winsey will continue as Managing Director until the end of the year to facilitate a smooth transition and Dr Bucknell will remain with the company as Technical Director.

 

Dia-Stron's stand-alone accounts for the financial year to 31 March 2015 show revenues of £1.48 million and pre-tax profits of £0.59 million. Net tangible assets amounted to £0.81 million, including cash of £0.55 million. These accounts do not include the assets or profits of Dia-Stron US and Mar-Tech which were acquired by Dia-Stron prior to completion of the Acquisition and are not material in the context of the transaction.

 

Dia-Stron's operating profits for the 12-month period ended 30 August 2015, adjusted (i) to include the profit contribution of Dia-Stron US and an estimate of the recurring annual profit of Mar-Tech and (ii) to eliminate non-recurring items and to reflect Dia-Stron's ongoing cost base within Judges, would have totalled £0.66 million on sales of £1.67 million. Dia-Stron owns a long leasehold property valued at £0.14 million.

 

Financing of the Acquisition

The Acquisition and associated transaction costs are being financed from Judges' existing cash resources.

 

The Board believes that Dia-Stron is an attractive and highly innovative business which enjoys a strong position in its worldwide niche market and an excellent reputation for quality and service.

 

Alex Hambro, Chairman of Judges, commented:

 

"Dia-Stron is an excellent company which has developed a first class reputation in its niche market and can be expected to have a positive and immediate impact on the Group's financial performance. We are delighted to welcome Nigel, Steve and their colleagues to Judges' management team."

 

- Ends -

 

 

 

 

For further information please contact:

 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, FD

 

Tel: 020 3829 6970

 

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Edward Mansfield

 

Tel: 020 7408 4090

 

Abchurch (Financial Public Relations)

Philip Dennis

Quincy Allan

Nessyah Hart

Tel: 020 7398 7700

 

 

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group holds 5 Queens' awards for innovation and export.

 

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQAKDDNBBKBDNN
Date   Source Headline
8th Aug 20142:29 pmRNSDirector/PDMR Shareholding
22nd Jul 20147:00 amRNSDirector/PDMR Shareholding
18th Jul 20143:14 pmRNSHolding(s) in Company
17th Jul 20147:00 amRNSTrading Statement
9th Jul 20145:24 pmRNSDirector/PDMR Shareholding
6th Jun 20143:52 pmRNSDirector/PDMR Shareholding
5th Jun 201412:03 pmRNSIssue of Equity
3rd Jun 20144:15 pmRNSDirector/PDMR Shareholding
23rd May 20143:20 pmRNSExercise of options
22nd May 20147:00 amRNSPayment of deferred consideration for Scientifica
19th May 20143:08 pmRNSExercise of options
12th May 20141:54 pmRNSDirector/PDMR Shareholding
24th Apr 20145:30 pmRNSExercise of Options
10th Apr 201412:01 pmRNSExercise of options
8th Apr 20146:15 pmRNSDirector/PDMR Shareholding
4th Apr 20142:28 pmRNSExercise of Options
28th Mar 20147:00 amRNSFinal Results
10th Mar 201410:00 amRNSNotice of Results
10th Mar 20148:51 amRNSDirector/PDMR Shareholding
7th Feb 20142:53 pmRNSDirector/PDMR Shareholding
24th Jan 20147:00 amRNSTrading Statement
22nd Jan 20142:01 pmRNSExercise of Options
13th Jan 20141:40 pmRNSHolding(s) in Company
10th Jan 20146:00 pmRNSHolding(s) in Company
9th Jan 20144:34 pmRNSDirector/PDMR Shareholding
13th Dec 201310:31 amRNSIssue of Equity
10th Dec 20138:39 amRNSDirector/PDMR Shareholding
4th Dec 20134:06 pmRNSIssue of Equity
26th Nov 20133:31 pmRNSDirector/PDMR Shareholding
20th Nov 20137:00 amRNSTrading Statement
7th Nov 20132:04 pmRNSDirector/PDMR Shareholding
25th Oct 20135:24 pmRNSHolding(s) in Company
25th Oct 20134:19 pmRNSDirector/PDMR Shareholding
21st Oct 20137:00 amRNSPlacing to raise GBP8.125 million
9th Oct 20131:25 pmRNSDirector/PDMR Shareholding
2nd Oct 20135:47 pmRNSHolding(s) in Company
26th Sep 20137:00 amRNSHalf Yearly Report
17th Sep 20134:17 pmRNSNotice of Results
9th Sep 20134:15 pmRNSDirector/PDMR Shareholding
13th Aug 201312:48 pmRNSHolding(s) in Company
6th Aug 20134:33 pmRNSDirector/PDMR Shareholding
18th Jul 20132:04 pmRNSDirector/PDMR Shareholding
18th Jul 20137:00 amRNSTrading Statement
15th Jul 20134:59 pmRNSExercise of Options
10th Jul 20131:27 pmRNSExercise of options
9th Jul 20137:00 amRNSDirector/PDMR Shareholding and Issue of Equity
27th Jun 20134:52 pmRNSHolding(s) in Company
27th Jun 20137:00 amRNSAcquisition and Trading Update
7th Jun 20133:24 pmRNSDirector/PDMR Shareholding
29th May 20135:17 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.